NervGen Pharma (9UA.MU) Q2 2026 Earnings

15MayConfirmed
Q2 2026
-0.06
-0.05
-0.03
-0.01

Details

Expected EPS
-0.06361191069000001
Actual EPS
-0.01250200146
Surprise EPS
0.05
Surprise Percent
+80.35%

Description

NervGen Pharma (9UA.MU) has reported earnings of -0.01250200146 per share for Q2 2026.

0 Comments

Share your thoughts